Original Research
Accepted on 02 Sep 2024
PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma
in Head and Neck Cancer
Original Research
Accepted on 02 Sep 2024
in Head and Neck Cancer
Editorial
Accepted on 02 Sep 2024
in Clinical Diabetes
Original Research
Accepted on 02 Sep 2024
in Head and Neck Cancer
Original Research
Accepted on 02 Sep 2024
in Gynecological Oncology
Original Research
Accepted on 02 Sep 2024
in Head and Neck Cancer
Original Research
Accepted on 02 Sep 2024
in Nutritional Epidemiology
Review
Accepted on 02 Sep 2024
in Gastrointestinal Sciences
Original Research
Accepted on 02 Sep 2024
in Animal Nutrition and Metabolism
Mini Review
Accepted on 02 Sep 2024
in Chemical Biology
Hypothesis and Theory
Accepted on 02 Sep 2024
in Work, Employment and Organizations
Original Research
Accepted on 02 Sep 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 02 Sep 2024
in Cancer Genetics
Methods
Accepted on 02 Sep 2024
in Veterinary Imaging
Brief Research Report
Accepted on 02 Sep 2024
in Quantitative Psychology and Measurement
Original Research
Accepted on 02 Sep 2024
in Stroke in the Young
Original Research
Accepted on 02 Sep 2024
in Avian Physiology